Hypertension prevalence among Chinese adults was 37.7% with a treatment rate of 44.6% and a control rate of 18.6% from 2016 to 2022.
Meta-Analysis (n=465,805)
What are the prevalence, treatment, and control rates of hypertension among Chinese adults from 2016 to 2022?
This meta-analysis highlights the ongoing public health challenge of hypertension in China and the need for optimized prevention and control measures.
Hypertension remains a major public health challenge in China. It is essential not only to improve hypertension prevention strategies but also to optimize hypertension control measures while accounting for regional variations and age-related differences.
Qi et al. (2026) conducted a meta-analysis in Hypertension (n=465,805). Hypertension prevalence among Chinese adults was 37.7% with a treatment rate of 44.6% and a control rate of 18.6% from 2016 to 2022.